OTC Markets OTCQX - Delayed Quote USD
MariMed Inc. (MRMD)
At close: November 5 at 3:46 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
156,070.0000
148,598.0000
134,010.0000
121,464.0000
50,895.1510
Cost of Revenue
88,534.0000
82,679.0000
70,053.0000
55,201.0000
19,570.2570
Gross Profit
67,536.0000
65,919.0000
63,957.0000
66,263.0000
31,324.8940
Operating Expense
58,234.0000
50,721.0000
38,875.0000
37,538.0000
15,811.7490
Operating Income
9,302.0000
15,198.0000
25,082.0000
28,725.0000
15,513.1450
Net Non Operating Interest Income Expense
-7,286.0000
-8,915.0000
-734.0000
-2,247.0000
-9,654.1300
Other Income Expense
-11,828.0000
-12,879.0000
-4,840.0000
-2,662.0000
-1,362.6990
Pretax Income
-9,812.0000
-6,596.0000
19,508.0000
23,816.0000
4,496.3160
Tax Provision
7,527.0000
9,411.0000
5,894.0000
16,192.0000
2,067.0490
Net Income Common Stockholders
-17,377.0000
-16,031.0000
13,468.0000
7,225.0000
2,143.9890
Diluted NI Available to Com Stockholders
-17,377.0000
-16,031.0000
13,468.0000
7,225.0000
2,143.9890
Basic EPS
-0.05
-0.04
0.04
0.02
0.01
Diluted EPS
-0.05
-0.04
0.04
0.02
0.01
Basic Average Shares
376,044.5000
363,403.0000
337,697.0000
326,467.0000
266,980.1970
Diluted Average Shares
376,044.5000
363,403.0000
380,289.0000
372,397.0000
324,160.5250
Total Operating Income as Reported
8,680.0000
14,385.0000
20,369.0000
26,863.0000
14,530.6570
Total Expenses
146,768.0000
133,400.0000
108,928.0000
92,739.0000
35,382.0060
Net Income from Continuing & Discontinued Operation
-17,377.0000
-16,031.0000
13,468.0000
7,225.0000
2,143.9890
Normalized Income
-8,645.1300
-7,148.2400
16,833.0820
8,584.2600
3,116.4410
Interest Income
107.0000
270.0000
959.0000
109.0000
156.3450
Interest Expense
7,393.0000
9,185.0000
1,693.0000
2,356.0000
9,810.4750
Net Interest Income
-7,286.0000
-8,915.0000
-734.0000
-2,247.0000
-9,654.1300
EBIT
-2,419.0000
2,589.0000
21,201.0000
26,172.0000
14,306.7910
EBITDA
7,700.0000
11,163.0000
25,915.0000
28,960.0000
16,488.8820
Reconciled Cost of Revenue
88,534.0000
82,679.0000
70,053.0000
55,201.0000
19,570.2570
Reconciled Depreciation
10,119.0000
8,574.0000
4,714.0000
2,788.0000
2,182.0910
Net Income from Continuing Operation Net Minority Interest
-17,377.0000
-16,031.0000
13,468.0000
7,225.0000
2,143.9890
Total Unusual Items Excluding Goodwill
-11,053.0000
-11,244.0000
-4,713.0000
-1,862.0000
-1,332.1260
Total Unusual Items
-11,053.0000
-11,244.0000
-4,713.0000
-1,862.0000
-1,332.1260
Normalized EBITDA
18,753.0000
22,407.0000
30,628.0000
30,822.0000
17,821.0080
Tax Rate for Calcs
0.0002
0.0002
0.0003
0.0003
0.0003
Tax Effect of Unusual Items
-2,321.1300
-2,361.2400
-1,347.9180
-502.7400
-359.6740
12/31/2020 - 8/3/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CBSTF The Cannabist Company Holdings Inc.
0.2067
-1.15%
VRNOF Verano Holdings Corp.
3.2400
-6.09%
AYRWF Ayr Wellness Inc.
2.3000
-6.12%
JUSHF Jushi Holdings Inc.
0.4479
-3.95%
GTBIF Green Thumb Industries Inc.
10.70
0.00%
TSNDF TerrAscend Corp.
1.0000
-4.76%
CRLBF Cresco Labs Inc.
1.5200
-0.65%
VREOF Vireo Growth Inc.
0.4400
-2.18%
ITHUF iAnthus Capital Holdings, Inc.
0.0090
+9.76%
GRUSF Grown Rogue International Inc.
0.6500
+1.56%